查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1621613

動物疫苗市場：按動物類型、技術、給藥途徑、分銷管道分類 - 全球預測 2025-2030

Veterinary Vaccines Market by Animal Type (Aquaculture, Companion Animals, Livestock), Technology (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines), Route of Administration, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年動物疫苗市值為98.2億美元，預計2024年將達104億美元，複合年成長率為6.43%，預計2030年將達到151.9億美元。

動物疫苗市場包括開發和生產專為動物設計的疫苗，以預防疾病、促進健康並提高牲畜和伴同性動物的生產力。這些疫苗對於預防通用感染疾病的爆發、降低動物死亡率和最大限度地減少農業部門的經濟損失至關重要。其用途範圍從牛、家禽等牲畜到寵物。這個多元化的市場主要是由動物保健支出增加、牲畜數量增加以及對動物性食品的需求增加等因素所推動的。此外，寵物擁有量的增加也推動了對伴同性動物疫苗的需求。關鍵的成長要素包括推動新疫苗開發的生物技術進步以及支持動物健康的政府措施。在亞太和非洲等尚未開發的地區，畜牧業產量正在迅速成長，因此存在擴大服務的潛在機會。您可以透過與當地獸醫院合作並探索適合您需求的疫苗接種策略來進一步提高市場滲透率。然而，疫苗儲存和運輸成本高、監管障礙以及牲畜所有者對疫苗猶豫不決等挑戰正在限制成長。此外，人們普遍缺乏對動物健康實踐的認知，特別是在開發中地區。在技​​術創新方面，開發頻譜且提供持久免疫力的疫苗可能會改變遊戲規則。 DNA 疫苗和重組疫苗等生物技術創新是利潤豐厚的研發領域。儘管成長軌跡充滿希望，但市場競爭仍較為激烈，知名公司大力投資研發併購，以擴大其產品線和市場。透過策略教育措施和加強分銷網路來解決限制對於永續成長至關重要。公司應注重監管合規性，以避免潛在的陷阱，並支持提高對動物健康和疫苗接種益處的認知的努力。

主要市場統計
基準年[2023] 98.2億美元
預計年份 [2024] 104億美元
預測年份 [2030] 151.9億美元
複合年成長率（%） 6.43%

市場動態：揭示快速發展的獸用疫苗市場的關鍵市場洞察

供需的動態交互作用正在改變動物疫苗市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 飼養的伴同性動物和牲畜數量增加
    • 動物慢性病和意外傷害發生率增加
    • 政府針對獸醫動物疫苗接種的舉措
  • 市場限制因素
    • 疫苗開發、儲存和處理相關的高成本
  • 市場機會
    • 從減毒活病毒疫苗到 DNA 疫苗的過渡
    • 加大投資和研發力度，開發新型動物疫苗
  • 市場挑戰
    • 對嚴格監管合規的擔憂

波特五力：駕馭動物疫苗市場的策略工具

波特的五力框架是了解獸用疫苗市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解獸用疫苗市場的外部影響

外部宏觀環境因素對獸用疫苗市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解動物疫苗市場競爭狀況

對獸用疫苗市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣獸用疫苗市場供應商的績效評估

FPNV定位矩陣是評估獸用疫苗市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃獸用疫苗市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對動物疫苗市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開發：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、未開發地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 飼養寵物和牲畜的數量增加
      • 動物慢性病和意外傷害發生率增加
      • 政府關於獸醫動物疫苗接種的舉措
    • 抑制因素
      • 疫苗開發、儲存和處理相關的高成本
    • 機會
      • 從減毒活疫苗到 DNA 疫苗的轉變
      • 加大獸用疫苗新開發研發投入
    • 任務
      • 對嚴格監管合規的擔憂
  • 市場區隔分析
    • 動物類型：增加使用疫苗預防牲畜疾病
    • 技術：增加去活化感測器的使用，減輕狂犬病、流感、鉤端螺旋體病等針對性疾病的負擔
    • 給藥途徑：鼻內給藥由於其易於使用和非侵入性而越來越受到青睞。
    • 分銷管道：提高獸醫院和診所的疫苗供應
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章動物疫苗市場：依動物類型

  • 水產養殖
  • 伴同性動物
  • 家畜
    • 牛
    • 豬肉
    • 家禽
    • 小反芻動物

第7章動物疫苗市場：依技術分類

  • 去活化疫苗
  • 減毒活疫苗
  • 重組疫苗
  • 類毒素疫苗

第8章動物疫苗市場：依給藥途徑分類

  • 靜脈
  • 鼻腔
  • 口服

第9章動物疫苗市場：依通路分類

  • 醫院/診所
  • 零售藥房

第10章美洲動物疫苗市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太動物疫苗市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲動物疫苗市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 默克動物保健推出 3 劑豬疫苗
    • IIL投資70億印度盧比在印度海得拉巴建立新的動物疫苗部門
    • 默克動物保健公司收購 Benk
  • 戰略分析和建議

公司名單

  • Addison Biological Laboratory Inc.
  • Aptimmune Biologics, Inc
  • Bimeda Inc.
  • Biokema SA
  • Boehringer Ingelheim International GmbH
  • Brilliant Bio Pharma Private Limited
  • Ceva Sante Animale
  • China Animal Husbandry Industry Co., Ltd
  • Covetrus, Inc.
  • Elanco Animal Health Incorporated
  • Endovac Animal Health.
  • Hester Biosciences Limited
  • HIPRA, SA
  • Indian Immunologicals Ltd.
  • Kemin Industries, Inc.
  • Kyoritsuseiyaku Corporation
  • Laboratoire LCV
  • Meiji Holdings Co., Ltd.
  • Merck & Co., Inc
  • Neogen Corporation
  • Norbrook Laboratories Limited
  • Phibro Animal Health Corporation
  • Saiba Animal Health AG
  • Sumitomo Pharma Animal Health Co., Ltd.
  • Torigen Pharmaceuticals Inc.
  • Vaxxinova International BV
  • Virbac SA
  • YEBIO BIOENGINEERING CO., LTD OF QINGDAO
  • Zoetis Inc.
Product Code: MRR-4316E4E89380

The Veterinary Vaccines Market was valued at USD 9.82 billion in 2023, expected to reach USD 10.40 billion in 2024, and is projected to grow at a CAGR of 6.43%, to USD 15.19 billion by 2030.

The veterinary vaccines market encompasses the development and production of vaccines tailored for animals to prevent diseases, enhance health, and improve productivity across livestock and companion animals. These vaccines are essential for preventing outbreaks of zoonotic diseases, reducing animal mortality, and minimizing economic losses in the agricultural sector. Their application covers livestock, such as cattle and poultry, and extends to pets. This diverse market is primarily driven by factors like rising animal healthcare expenditure, an increase in livestock population, and growing demand for animal-derived food products. Additionally, the increased pet adoption rates fuel the demand for companion animal vaccines. Key growth influencers include advancements in biotechnology, which have propelled the development of novel vaccines, and governmental initiatives supporting animal health. Potential opportunities lie in expanding services in under-researched regions like Asia-Pacific and Africa, where livestock farming is burgeoning. Exploring partnerships with local veterinary clinics for tailored vaccination strategies can further enhance market penetration. However, challenges such as high costs of vaccine storage and transportation, regulatory hurdles, and vaccine hesitancy among livestock owners limit growth. Additionally, there's a widespread lack of awareness regarding animal health practices, particularly in developing regions. In terms of innovation, developing vaccines with broad-spectrum capabilities and those offering long-lasting immunity can be game-changing. Biotechnology innovations such as DNA and recombinant vaccines present lucrative R&D areas. Despite the promising growth trajectory, the market shows moderate competitive intensity with notable players investing heavily in R&D and mergers/acquisitions to augment product lines and market reach. Addressing limitations via strategic educational initiatives and enhancing distribution networks are pivotal for sustained growth. Businesses should focus on regulatory compliance to avoid potential pitfalls and support efforts to improve awareness about animal health and vaccination benefits.

KEY MARKET STATISTICS
Base Year [2023] USD 9.82 billion
Estimated Year [2024] USD 10.40 billion
Forecast Year [2030] USD 15.19 billion
CAGR (%) 6.43%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Vaccines Market

The Veterinary Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing number of companion animal and livestock ownership
    • Rising incidence of chronic diseases and accidental injuries in animals
    • Government initiatives for immunization of veterinary animals
  • Market Restraints
    • High cost associated with development, storage, and handling of vaccines
  • Market Opportunities
    • Shift from live attenuated vaccines to DNA vaccines
    • Rising investments and R&D for development of novel veterinary vaccines
  • Market Challenges
    • Concerns associated with stringent regulatory compliance

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Vaccines Market

A detailed market share analysis in the Veterinary Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Vaccines Market

A strategic analysis of the Veterinary Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Vaccines Market, highlighting leading vendors and their innovative profiles. These include Addison Biological Laboratory Inc., Aptimmune Biologics, Inc, Bimeda Inc., Biokema SA, Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private Limited, Ceva Sante Animale, China Animal Husbandry Industry Co., Ltd, Covetrus, Inc., Elanco Animal Health Incorporated, Endovac Animal Health., Hester Biosciences Limited, HIPRA, S.A, Indian Immunologicals Ltd., Kemin Industries, Inc., Kyoritsuseiyaku Corporation, Laboratoire LCV, Meiji Holdings Co., Ltd., Merck & Co., Inc, Neogen Corporation, Norbrook Laboratories Limited, Phibro Animal Health Corporation, Saiba Animal Health AG, Sumitomo Pharma Animal Health Co., Ltd., Torigen Pharmaceuticals Inc., Vaxxinova International BV, Virbac SA, YEBIO BIOENGINEERING CO., LTD OF QINGDAO, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Animal Type, market is studied across Aquaculture, Companion Animals, and Livestock. The Livestock is further studied across Bovine, Porcine, Poultry, and Small Ruminants.
  • Based on Technology, market is studied across Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, and Toxoid Vaccines.
  • Based on Route of Administration, market is studied across Intravenous, Nasal, and Oral.
  • Based on Distribution Channel, market is studied across Hospitals & Clinics and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of companion animal and livestock ownership
      • 5.1.1.2. Rising incidence of chronic diseases and accidental injuries in animals
      • 5.1.1.3. Government initiatives for immunization of veterinary animals
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with development, storage, and handling of vaccines
    • 5.1.3. Opportunities
      • 5.1.3.1. Shift from live attenuated vaccines to DNA vaccines
      • 5.1.3.2. Rising investments and R&D for development of novel veterinary vaccines
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with stringent regulatory compliance
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Animal Type: Rising usage of vaccines for disease prevention in livestock animals
    • 5.2.2. Technology: Increasing use of inactivated sensors to reduce the burden of target diseases such as rabies, influenza, and leptospirosis
    • 5.2.3. Route of Administration: Growing preference for nasal administration owing to its user-friendly and non-invasive nature
    • 5.2.4. Distribution Channel: Rising accessibility of vaccines across veterinary hospitals & clinics
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Veterinary Vaccines Market, by Animal Type

  • 6.1. Introduction
  • 6.2. Aquaculture
  • 6.3. Companion Animals
  • 6.4. Livestock
    • 6.4.1. Bovine
    • 6.4.2. Porcine
    • 6.4.3. Poultry
    • 6.4.4. Small Ruminants

7. Veterinary Vaccines Market, by Technology

  • 7.1. Introduction
  • 7.2. Inactivated Vaccines
  • 7.3. Live Attenuated Vaccines
  • 7.4. Recombinant Vaccines
  • 7.5. Toxoid Vaccines

8. Veterinary Vaccines Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Intravenous
  • 8.3. Nasal
  • 8.4. Oral

9. Veterinary Vaccines Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospitals & Clinics
  • 9.3. Retail Pharmacies

10. Americas Veterinary Vaccines Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Veterinary Vaccines Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Veterinary Vaccines Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Merck Animal Health launches 3-in-one swine vaccine
    • 13.3.2. IIL to set up new animal vaccine unit in Hyderabad, India at INR 700 crore
    • 13.3.3. Merck Animal Health to Acquire Venc
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Addison Biological Laboratory Inc.
  • 2. Aptimmune Biologics, Inc
  • 3. Bimeda Inc.
  • 4. Biokema SA
  • 5. Boehringer Ingelheim International GmbH
  • 6. Brilliant Bio Pharma Private Limited
  • 7. Ceva Sante Animale
  • 8. China Animal Husbandry Industry Co., Ltd
  • 9. Covetrus, Inc.
  • 10. Elanco Animal Health Incorporated
  • 11. Endovac Animal Health.
  • 12. Hester Biosciences Limited
  • 13. HIPRA, S.A
  • 14. Indian Immunologicals Ltd.
  • 15. Kemin Industries, Inc.
  • 16. Kyoritsuseiyaku Corporation
  • 17. Laboratoire LCV
  • 18. Meiji Holdings Co., Ltd.
  • 19. Merck & Co., Inc
  • 20. Neogen Corporation
  • 21. Norbrook Laboratories Limited
  • 22. Phibro Animal Health Corporation
  • 23. Saiba Animal Health AG
  • 24. Sumitomo Pharma Animal Health Co., Ltd.
  • 25. Torigen Pharmaceuticals Inc.
  • 26. Vaxxinova International BV
  • 27. Virbac SA
  • 28. YEBIO BIOENGINEERING CO., LTD OF QINGDAO
  • 29. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. VETERINARY VACCINES MARKET RESEARCH PROCESS
  • FIGURE 2. VETERINARY VACCINES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. VETERINARY VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. VETERINARY VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VETERINARY VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VETERINARY VACCINES MARKET DYNAMICS
  • TABLE 7. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY VACCINES MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY VACCINES MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY VACCINES MARKET SIZE, BY BOVINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY VACCINES MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY VACCINES MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY VACCINES MARKET SIZE, BY SMALL RUMINANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY VACCINES MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY VACCINES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY VACCINES MARKET SIZE, BY NASAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY VACCINES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 237. VETERINARY VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. VETERINARY VACCINES MARKET, FPNV POSITIONING MATRIX, 2023